Table 2.
Summary Outcomes: Antibiotic Prescriptions by Country and Overall
| Country | Patients With ATBs Prescribed/Total in Group, No. (%) | Effect | |||
|---|---|---|---|---|---|
| Intervention Group | Control Group | Relative: Risk Ratio (RR) (95% CI) |
Absolute: Risk Difference (RD) (95% CI) |
No. Needed to Testa | |
| Burkina Faso | 343/844 (40.6) | 481/837 (57.5) | 29% Reduction (−22% to −36%) |
17 Fewer ATB Rx per 100 patients tested (12–22 fewer) |
1 Fewer ATB Rx for every 6 patients tested (range: 8 to 5 patients) |
| Ghana | 294/760 (38.7) | 323/745 (43.4) | 11% Reduction (−21% to 1%) |
5 Fewer ATB Rx per 100 patients tested (0–10 fewer) |
1 Fewer ATB Rx for every 21 patients tested (range: from 1 fewer for every 10 patients, to 1 more for every 340 patients) |
| Uganda | 396/703 (56.3) |
366/782 (46.8) |
20% Increase (9%–33%) |
10 More ATB Rx per 100 patients tested (4–15 more) |
1 More ATB Rx for every 10 patients tested (range: 25 to 7 patients) |
| All countries | 1033/2307 (44.8) |
1170/2364 (49.5) |
9% Reduction (−3% to −15%) |
5 Fewer ATB Rx per 100 patients tested (2–7 fewer) |
1 Fewer ATB Rx for every 20 patients tested (range: 50 to 14 patients) |
Abbreviations: ATB, antibiotic; CI, confidence interval; RD, risk difference; RR, risk ratio; Rx, prescription(s).
Number needed to test to prevent 1 more ATB Rx if results were negative (or lead to 1 more if they were positive).